Source: Health Products Regulatory Authority (ZA) Revision Year: 2023 Publisher: Pharmacorp (Pty) Ltd, 29 Victoria Link, Route 21 Corporate Park, Irene, 0178, Pretoria
PONAC CAPSULES 250 mg.
| Pharmaceutical Form |
|---|
|
Capsules. A no. 1 capsule with a turquoise cap and pale-yellow body. |
Each capsule contains 250 mg of mefenamic acid.
Contains sugar: Lactose monohydrate 55 mg per capsule.
For full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. |
| List of Excipients |
|---|
|
Brilliant blue (E133) |
PONAC CAPSULES are either packed in a PP container with LDPE closure cap with foam insert and silica gel sachet or in blister packs (foil and blister PVC).
Pack size: 100’s.
Not all packs may be marketed.
Pharmacorp (Pty) Ltd, 29 Victoria Link, Route 21 Corporate Park, Irene, 0178, Pretoria
Y/2.7/157
Date of first authorization: 05 July 1991
| Drug | Countries | |
|---|---|---|
| PONAC | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.